相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antioxidant Therapeutics for Schizophrenia
Ravinder Reddy et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Antipsychotic Medication and Oxidative Cell Stress: A Systematic Review
Peter Lepping et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Short Term Dietary Fish Oil Supplementation Improves Motor Deficiencies Related to Reserpine-Induced Parkinsonism in Rats
Raquel Cristine Silva Barcelos et al.
LIPIDS (2011)
Oxidative stress in schizophrenia: An integrated approach
Byron K. Y. Bitanihirwe et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Antipsychotic-Induced DRD2 Upregulation and Its Prevention by α-Lipoic Acid in SH-SY5Y Neuroblastoma Cells
Jessica Deslauriers et al.
SYNAPSE (2011)
Haloperidol causes cytoskeletal collapse in N1E-115 cells through tau hyperphosphorylation induced by oxidative stress: Implications for neurodevelopment
Gloria Benitez-King et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia
Vidhi Singh et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole
H. G. Shertzer et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
Clozapine Treatment Causes Oxidation of Proteins Involved in Energy Metabolism in Lymphoblastoid Cells: A Possible Mechanism for Antipsychotic-Induced Metabolic Alterations
Muhammad R. Baig et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2010)
Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics
Manuela Padurariu et al.
NEUROSCIENCE LETTERS (2010)
Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients
Cedo Mijevic et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
A meta-analysis of oxidative stress markers in schizophrenia
Zhang Ming et al.
SCIENCE CHINA-LIFE SCIENCES (2010)
Inhibitory effects of polyphenol compounds on lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in human plasma in vitro
Anna Dietrich-muszalska et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Protective role of selenium supplementation against cardiac lesions induced by the combination of levomepromazine and risperidone in the rabbit
W. Manati et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2009)
Comparing the Effects of High-Dose Vitamin E With Those of Placebo on Insulin Resistance in Patients With Schizophrenia Treated With Olanzapine
Fiona Baroyant Salmasi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats
Santhrani Thaakur et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line
Andrea Tarozzi et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Nrf2 Activators Provide Neuroprotection Against 6-Hydroxydopamine Toxicity in Rat Organotypic Nigrostriatal Cocultures
Aubrey Siebert et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Oxidative stress, nitric oxide and prostaglandin E2levels in the gastrointestinal tract of aging rats
Frederic Mármol et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2009)
Impact of haloperidol and quetiapine on the expression of genes encoding antioxidant enzymes in human neuroblastoma SH-SY5Y cells
Andreas Johannes Schmidt et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
Roles of Glutathione (GSH) in Dopamine (DA) Oxidation Studied by Improved Tandem HPLC Plus ESI-MS
Zhi Dong Zhou et al.
NEUROCHEMICAL RESEARCH (2009)
Sulforaphane improves cognitive function administered following traumatic brain injury
Prarnod K. Dash et al.
NEUROSCIENCE LETTERS (2009)
Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels
Mahendra Bishnoi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients
Monia Raffa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia
OmPrakash Singh et al.
Indian Journal of Psychiatry (2009)
N-acetyl cysteine as a glutathione precursor for schizophrenia - A double-blind, randomized, placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
John McGrath et al.
EPIDEMIOLOGIC REVIEWS (2008)
Demonstration of an anti-oxidative stress mechanism of quetiapine - Implications for the treatment of Alzheimer's disease
Haiyun Xu et al.
FEBS JOURNAL (2008)
Clozapine causes oxidation of proteins involved in energy metabolism: a possible mechanism for antipsychotic-induced metabolic alterations
Consuelo Walss-Bass et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
A preliminary investigation of α-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia
Eosu Kim et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Antipsychotic-induced oxidative stress in rat brain
Marcio R. Martins et al.
NEUROTOXICITY RESEARCH (2008)
Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain
Mahendra Bishnoi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Effect of chronic N-acetyl cysteine administration on oxidative status in the presence and absence of induced oxidative stress in rat striatum
Brian H. Harvey et al.
NEUROCHEMICAL RESEARCH (2008)
Vitamin B6 treatment for tardive dyskinesia:: A randomized, double-blind, placebo-contyolled, crossover study
Vladimir Lerner et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes
Mahendra Bishnoi et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2007)
The impact of ω-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol:: An open-label pilot study
E. Y. Sivrioglu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Ilex paraguariensis has antioxidant potential and attenuates haloperidol-induced orofacial dyskinesia and memory dysfunction in rats
Gabriela Colpo et al.
NEUROTOXICITY RESEARCH (2007)
Neuronal apoptosis in neurodegeneration
Masahiro Okouchi et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Protective effect of sulforaphane against dopaminergic cell death
Ji Man Han et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Induction of apoptosis in HT-29 cells by extracts from isothiocyanates - rich varieties of Brassica oleracea
Sergi Mas et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2007)
Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics
XY Zhang et al.
SCHIZOPHRENIA RESEARCH (2006)
Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method
Irfan Rahman et al.
NATURE PROTOCOLS (2006)
Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: A clinical phase I study
Theresa A. Shapiro et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2006)
Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia
GN Dakhale et al.
PSYCHOPHARMACOLOGY (2005)
Olanzapine and quetiapine protect PC12 cells from β-amyloid peptide25-35-induced oxidative stress and the ensuing apoptosis.
HT Wang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Oxidative stress during treatment with first- and second-generation antipsychotics
S Kropp et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2005)
Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats
ME Burger et al.
BRAIN RESEARCH (2005)
Induction of NAD(P)H quinone, oxidoreductase by vegetables widely consumed in Catalonia, Spain
N Laso et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2005)
Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra
FL van Muiswinkel et al.
NEUROBIOLOGY OF AGING (2004)
Supplementation with a combination of ω-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia
M Arvindakshan et al.
SCHIZOPHRENIA RESEARCH (2003)
Oxidative stress in Parkinson's disease
P Jenner
ANNALS OF NEUROLOGY (2003)
Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease
M Asanuma et al.
NEUROTOXICITY RESEARCH (2003)
Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain
V Parikh et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2003)
Evaluation of the neurotoxic activity of typical and atypical neuroleptics: Relevance to latrogenic extrapyramidal symptoms
I Gil-Ad et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2001)
Mechanism of NAD(P)H:quinone reductase:: Ab initio studies of reduced flavin
G Cavelier et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2001)
Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones
A Dagnino-Subiabre et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
